Search research articles
Contact Us
Filters
Showing results (461-470 of 740) with videos related to
Page
of 74
Sort By:
Annals of Hematology
|
March 6, 2019
Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome
Georgia Trakada, Efstathios Kastritis, Maria Gavriatopoulou, et al.
Clinical Pharmacology : Advances and Applications
|
November 30, 2017
Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function
Yan Li, Xiaomin Wang, Edward O'Mara, et al.
Blood Cancer Journal
|
November 5, 2020
Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients
Despina Fotiou, Maria Roussou, Charikleia Gakiopoulou, et al.
Journal of Clinical Medicine
|
June 10, 2022
Newly Diagnosed Multiple Myeloma Patients with Skeletal-Related Events and Abnormal MRI Pattern Have Poor Survival Outcomes: A Prospective Study on 370 Patients
Nikolaos Kanellias, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, et al.
Leukemia
|
July 21, 2018
Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies
Tina Bagratuni, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, et al.
Scientific Reports
|
March 23, 2021
The relationship between cardiac injury, inflammation and coagulation in predicting COVID-19 outcome
Alessandro Mengozzi, Georgios Georgiopoulos, Marco Falcone, et al.
Scientific Reports
|
March 24, 2021
Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays
Christos Fotis, Nikolaos Meimetis, Nikos Tsolakos, et al.
BMC Medicine
|
August 23, 2021
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients
Ioannis P Trougakos, Evangelos Terpos, Christina Zirou, et al.
Haematologica
|
November 27, 2014
Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma
Kevin W Song, Meletios A Dimopoulos, Katja C Weisel, et al.
Journal of Clinical Pharmacology
|
December 8, 2016
Population Pharmacokinetics and Exposure-Response Relationship of Carfilzomib in Patients With Multiple Myeloma
Ying Ou, Sameer Doshi, Anh Nguyen, et al.
Page
of 74
Search research articles
Search
Showing results (461-470 of 740) with videos related to
Sort By:
Page
of 74
Annals of Hematology
|
March 6, 2019
Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome
Georgia Trakada, Efstathios Kastritis, Maria Gavriatopoulou, et al.
Clinical Pharmacology : Advances and Applications
|
November 30, 2017
Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function
Yan Li, Xiaomin Wang, Edward O'Mara, et al.
Blood Cancer Journal
|
November 5, 2020
Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients
Despina Fotiou, Maria Roussou, Charikleia Gakiopoulou, et al.
Journal of Clinical Medicine
|
June 10, 2022
Newly Diagnosed Multiple Myeloma Patients with Skeletal-Related Events and Abnormal MRI Pattern Have Poor Survival Outcomes: A Prospective Study on 370 Patients
Nikolaos Kanellias, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, et al.
Leukemia
|
July 21, 2018
Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies
Tina Bagratuni, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, et al.
Scientific Reports
|
March 23, 2021
The relationship between cardiac injury, inflammation and coagulation in predicting COVID-19 outcome
Alessandro Mengozzi, Georgios Georgiopoulos, Marco Falcone, et al.
Scientific Reports
|
March 24, 2021
Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays
Christos Fotis, Nikolaos Meimetis, Nikos Tsolakos, et al.
BMC Medicine
|
August 23, 2021
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients
Ioannis P Trougakos, Evangelos Terpos, Christina Zirou, et al.
Haematologica
|
November 27, 2014
Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma
Kevin W Song, Meletios A Dimopoulos, Katja C Weisel, et al.
Journal of Clinical Pharmacology
|
December 8, 2016
Population Pharmacokinetics and Exposure-Response Relationship of Carfilzomib in Patients With Multiple Myeloma
Ying Ou, Sameer Doshi, Anh Nguyen, et al.
Page
of 74